NUVL

Nuvalent Inc-A

NASDAQ · Biotechnology

$103.59

+2.69 (+2.67%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

24 analysts

Buy 23 96%

Hold 1 4%

Sell 0 0%

Price Target

Analyst Price Target -67.9% upside

Low Target $20.12

Average Target $33.28

High Target $44.46

Current Price $103.59

Current
$103.59

Target
$33.28

$20.12 $33.28 avg $44.46